Globe Life Inc. (NYSE: GL) is a Financial Services company in the Insurance - Life industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 12.00 | EPS (ttm) | 15.32 | Insider Own | 1.15% | Shs Outstand | 77.64M | Perf Week | 0.88% |
| Market Cap | 14.27B | Forward P/E | 11.15 | EPS next Y | 16.49 | Insider Trans | -47.25% | Shs Float | 77.02M | Perf Month | 2.79% |
| Enterprise Value | 14.30B | PEG | 0.56 | EPS next Q | 4.86 | Inst Own | - | Short Float | 2.34% | Perf Quarter | 20.60% |
| Income | 1.20B | P/S | 2.30 | EPS this Y | 94.97% | Inst Trans | - | Short Ratio | 3.00 | Perf Half Y | 25.11% |
| Sales | 6.20B | P/B | 2.34 | EPS next Y | 4.95% | ROA | 3.84% | Short Interest | 1.80M | Perf YTD | 31.45% |
| Book/sh | - | P/C | 7.95 | EPS next 5Y | 7.46% | ROE | 20.28% | 52W High | 192.40 -4.02% | Perf Year | 30.18% |
| Cash/sh | - | P/FCF | 8.77 | EPS past 3/5Y | 15.86% 15.57% | ROIC | 17.43% | 52W Low | 128.42 43.80% | Perf 3Y | 62.08% |
| Dividend Est. | 1.32 (0.71%) | EV/EBITDA | 22.66 | Sales past 3/5Y | 4.70% 4.83% | Gross Margin | 17.00% | Volatility | 2.00% 2.16% | Perf 5Y | 97.45% |
| Dividend TTM | 1.20 (0.65%) | EV/Sales | 2.31 | EPS Y/Y TTM | -32.50% | Oper. Margin | 9.23% | ATR (14) | 4.11 | Perf 10Y | 196.58% |
| Dividend Ex-Date | Jul 06, 2026 | Quick Ratio | 4.58 | Sales Y/Y TTM | 7.25% | Profit Margin | 19.56% | RSI (14) | 59.39 | Recom | 2.86 |
| Dividend Gr. 3/5Y | 8.61% 7.38% | Current Ratio | 4.58 | EPS Q/Q | 10.40% | SMA20 | 1.41% | Beta | 0.46 | Target Price | 177.80 |
| Payout | 9.24% | Debt/Eq | 0.05 | Sales Q/Q | 8.04% | SMA50 | 5.95% | Rel Volume | 0.82 | Prev Close | 183.85 |
| Employees | 3,695 | LT Debt/Eq | 0.39 | Earnings | Oct 28 | SMA200 | 22.78% | Avg Volume | 656.20K | Price | 184.67 |
| IPO Date | Oct 01, 1980 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -1.72% 0.59% | Net Debt/EBITDA | 0.03 | Volume | 537,672 | Change | 0.45% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-15-26 | Reiterated | Piper Sandler | Overweight | $175 → $200 |
| Jul-10-26 | Reiterated | Jefferies | Hold | $90 → $166 |
| May-26-26 | Reiterated | Piper Sandler | Overweight | $167 → $175 |
| May-21-26 | Reiterated | Morgan Stanley | Overweight | $176 → $181 |
| Apr-24-26 | Reiterated | Truist Securities | Buy | $158 → $185 |
| Feb-18-26 | Reiterated | Evercore ISI Group | In Line | $95 → $157 |
| Dec-15-25 | Reiterated | Morgan Stanley | Overweight | $177 → $176 |
| Nov-21-25 | Reiterated | Piper Sandler | Overweight | $106 → $167 |
| Oct-24-25 | Reiterated | Truist Securities | Buy | $90 → $158 |
| Oct-07-25 | Reiterated | Morgan Stanley | Overweight | $171 → $179 |
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6,197 | 5,999 | 5,778 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 5,143 | 3,995 | 3,908 | — | — | — | — | — | — | |
| Gross Profit | 1,054 | 2,004 | 1,870 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 320 | 198 | 383 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 162 | 343 | 161 | — | — | — | — | — | — | |
| Operating Income | 571 | 1,463 | 1,327 | — | — | — | — | — | — | |
| Interest Expense | 141 | 141 | 127 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 1,069 | 118 | 127 | — | — | — | — | — | — | |
| Net Income Before Taxes | 1,499 | 1,440 | 1,327 | — | — | — | — | — | — | |
| Income Taxes | 287 | 279 | 256 | — | — | — | — | — | — | |
| Consolidated Net Income | 1,213 | 1,161 | 1,071 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 1,213 | 1,161 | 1,071 | — | — | — | — | — | — | |
| Net Income | 1,213 | 1,161 | 1,071 | — | — | — | — | — | — | |
| EPS (Recurring) | 15.32 | 14.30 | 11.99 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 15.32 | 14.30 | 11.99 | — | — | — | — | — | — | |
| EPS (Diluted) | 15.10 | 14.06 | 11.94 | — | — | — | — | — | — | |
| EBITDA | 630 | 1,592 | 1,454 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 12.23 | 9.95 | 9.34 | — | — | — | — | — | — | |
| Price To Sales Ratio | 2.32 | 1.89 | 1.62 | — | — | — | — | — | — | |
| Gross Margin | 17.01 | 33.41 | 32.36 | — | — | — | — | — | — | |
| Operating Margin | 9.21 | 24.39 | 22.97 | — | — | — | — | — | — | |
| Net Margin | 19.57 | 19.35 | 18.54 | — | — | — | — | — | — | |
| Shares Outstanding | 78 | 81 | 84 | — | — | — | — | — | — | |
| Market Capitalization | 14,404 | 11,329 | 9,368 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Darden James Matthew | Co-Chairman & CEO | Jul 31 '26 | Sale | 182.43 | 50,000 | 9,121,638 | 58,451 | Aug 03 |
| Darden James Matthew | Co-Chairman & CEO | Jul 31 '26 | Option Exercise | 98.32 | 50,000 | 4,916,000 | 108,451 | Aug 03 |
| Kalmbach Thomas Peter | EVP & CFO | Jul 30 '26 | Option Exercise | 112.27 | 21,000 | 2,357,690 | 71,568 | Jul 30 |
| Kalmbach Thomas Peter | EVP & CFO | Jul 30 '26 | Sale | 180.06 | 21,000 | 3,781,163 | 50,568 | Jul 30 |
| MAJORS MICHAEL CLAY | EVP - Chief Strategy Officer | Jul 29 '26 | Option Exercise | 103.23 | 37,000 | 3,819,510 | 90,518 | Jul 30 |
| MAJORS MICHAEL CLAY | EVP - Chief Strategy Officer | Jul 29 '26 | Sale | 178.64 | 37,000 | 6,609,526 | 53,518 | Jul 30 |
| Kalmbach Thomas Peter | EVP & CFO | Jul 28 '26 | Option Exercise | 124.05 | 25,650 | 3,181,929 | 76,218 | Jul 29 |
| Kalmbach Thomas Peter | EVP & CFO | Jul 28 '26 | Sale | 178.58 | 25,650 | 4,580,564 | 50,568 | Jul 29 |
| Skarjune Dolores L | EVP and Chief Admin. Officer | Jun 30 '26 | Option Exercise | 103.23 | 1,850 | 190,976 | 15,547 | Jun 30 |
| Skarjune Dolores L | EVP and Chief Admin. Officer | Jun 30 '26 | Sale | 179.18 | 1,850 | 331,483 | 13,697 | Jun 30 |
| Alston Cheryl | Director | Jun 25 '26 | Option Exercise | 105.56 | 14,017 | 1,479,635 | 24,879 | Jun 26 |
| Alston Cheryl | Director | Jun 25 '26 | Sale | 179.24 | 8,258 | 1,480,134 | 16,621 | Jun 26 |
| Zorn Rebecca E | EVP & Chief Talent Officer | Jun 18 '26 | Option Exercise | 98.32 | 2,000 | 196,640 | 19,797 | Jun 22 |
| Zorn Rebecca E | EVP & Chief Talent Officer | Jun 18 '26 | Sale | 170.10 | 2,000 | 340,193 | 17,797 | Jun 22 |
| Skarjune Dolores L | EVP and Chief Admin. Officer | Jun 12 '26 | Sale | 166.18 | 4,175 | 693,794 | 13,697 | Jun 16 |